Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beloranib in Prader-Willi Syndrome
NCT01818921Phase 2Completed
- Sponsor
- Zafgen, Inc.
- Start
- Jun 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beloranib in Prader-Willi syndrome (PWS), sponsored by Zafgen, Inc.. Started Jun 2013; status: completed.
02
Drugs
beloranib
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT01818921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818921.